250 related articles for article (PubMed ID: 31389606)
1. LncRNA CADM1-AS1 serves as a new prognostic biomarker for gastric cancer.
Shi XY; Sun YZ; Li M; Li HY
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):232-238. PubMed ID: 31389606
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA ZEB1-AS1 is associated with poor prognosis in gastric cancer and promotes cancer cell metastasis.
Liu XJ; Li SL; Li JS; Lu H; Yin LL; Zheng WF; Wang WC
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2624-2630. PubMed ID: 29771411
[TBL] [Abstract][Full Text] [Related]
3. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
Feng Y; Zhang Q; Wang J; Liu P
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of lncRNA VPS9D1-AS1 in gastric cancer and its clinical significance.
Chen M; Wu X; Ma W; Zhou Q; Wang X; Zhang R; Wang J; Yang X
Cancer Biomark; 2017 Dec; 21(1):23-28. PubMed ID: 29036784
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas.
Yao J; Chen Y; Wang Y; Liu S; Yuan X; Pan F; Geng P
Int J Clin Exp Pathol; 2014; 7(6):2758-67. PubMed ID: 25031695
[TBL] [Abstract][Full Text] [Related]
7. LncRNA TRHDE-AS1 and MiR-1275 as Promising Prognostic Biomarkers and Effects on Tumor Cell Progression in Gastric Cancer.
Liu F; Cui J; Xue D
Tohoku J Exp Med; 2023 Sep; 261(1):13-23. PubMed ID: 36792178
[TBL] [Abstract][Full Text] [Related]
8. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
Deng J; Liang Y; Liu C; He S; Wang S
Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
[TBL] [Abstract][Full Text] [Related]
10. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.
Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q
World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090
[TBL] [Abstract][Full Text] [Related]
11. MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.
Li C; Wu R; Xing Y
Cell Cycle; 2020 Mar; 19(5):601-609. PubMed ID: 32079456
[TBL] [Abstract][Full Text] [Related]
12. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
[TBL] [Abstract][Full Text] [Related]
13. LncRNA ASMTL-AS1/microRNA-1270 differentiate prognostic groups in gastric cancer and influence cell proliferation, migration and invasion.
Song Z; Wang J
Bioengineered; 2022 Jan; 13(1):1507-1517. PubMed ID: 34986743
[TBL] [Abstract][Full Text] [Related]
14. The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1.
Zhao Y; Liu Y; Lin L; Huang Q; He W; Zhang S; Dong S; Wen Z; Rao J; Liao W; Shi M
Mol Cancer; 2018 Mar; 17(1):69. PubMed ID: 29510730
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer.
Zhou B; Jing XY; Wu JQ; Xi HF; Lu GJ
Int J Clin Exp Pathol; 2014; 7(12):8893-8. PubMed ID: 25674261
[TBL] [Abstract][Full Text] [Related]
16. Abnormally expressed long noncoding RNA B3GALT5-AS1 may serve as a biomarker for the diagnostic and prognostic of gastric cancer.
Feng W; Zong W; Li Y; Shen X; Cui X; Ju S
J Cell Biochem; 2020 Jan; 121(1):557-565. PubMed ID: 31338903
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA CERS6-AS1 plays a prognostic role in promoting the progression of gastric cancer.
Li Z; Liu X; Luo N; Pang Y; Hou Y; Jiang G
Bioengineered; 2021 Dec; 12(2):12931-12939. PubMed ID: 34852705
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.
Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L
Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.
Gong YB; Zou YF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4656-4662. PubMed ID: 31210291
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic significance of long noncoding RNA SSTR5-AS1 in patients with gastric cancer.
Cheng Y; Di J; Wu J; Shi HT; Zou BC; Zhang Y; Xie DH
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5385-5390. PubMed ID: 32495873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]